GM1 improves neurofascin155 association with lipid rafts and prevents rat brain myelin injury after hypoxia-ischemia

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 6, 2011, Pages 553-561

  Zhang, Y P ^a   Huang, Q L ^a   Zhao, C M ^a   Tang, J L ^a   Wang, Y L ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral hypoxia; Cerebral ischemia; Ganglioside; Myelin; Neurofascin 155

Indexed keywords

GANGLIOSIDE GM1; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUROFASCIN 155; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON MICROSCOPY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOCHEMISTRY; LIPID RAFT; MYELIN SHEATH; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; WESTERN BLOTTING;

RATTUS;

EID: 79958788087     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011000600009     Document Type: Article

References (28)

1. Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 2003; 4: 968-980.
2. Sherman DL, Tait S, Melrose S, Johnson R, Zonta B, Court FA, et al. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005; 48: 737-742.
3. Salzer JL. Polarized domains of myelinated axons. Neuron 2003; 40: 297-318.
4. Koticha D, Babiarz J, Kane-Goldsmith N, Jacob J, Raju K, Grumet M. Cell adhesion and neurite outgrowth are promoted by neurofascin NF155 and inhibited by NF186. Mol Cell Neurosci 2005; 30: 137-148.
5. Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, Denisenko-Nehrbass N, et al. Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Curr Biol 2002; 12: 217-220.
6. Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, et al. Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 2006; 129: 3173-3185.
7. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 2007; 55: 746-757.
8. Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW. The distribution of ganglioside-like moieties in peripheral nerves. Brain 1999; 122 (Part 3): 449-460.
9. Brown DA, London E. Structure and function of sphingolipid and cholesterol-rich membrane rafts. J Biol Chem 2000; 275: 17221-17224.
10. Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, et al. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 2002; 22: 6507-6514.
11. Dupree JL, Coetzee T, Suzuki K, Popko B. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol 1998; 27: 649-659.
12. Schafer DP, Bansal R, Hedstrom KL, Pfeiffer SE, Rasband MN. Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci 2004; 24: 3176-3185.
13. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, et al. The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol 2004; 166: 731-742.
14. Maier O, Baron W, Hoekstra D. Reduced raft-association of NF155 in active MS-lesions is accompanied by the disruption of the paranodal junction. Glia 2007; 55: 885-895.
15. Levine S. Anoxic-ischemic encephalopathy in rats. Am J Pathol 1960; 36: 1-17.
16. Rodier PM. Vulnerable periods and processes during central nervous system development. Environ Health Perspect 1994; 102 (Suppl 2): 121-124.
17. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, Inc.; 1997.
18. Maier O, van der Heide T, van Dam AM, Baron W, de Vries H, Hoekstra D. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis? Mol Cell Neurosci 2005; 28: 390-401.
19. Yates AJ. Gangliosides in the nervous system during development and regeneration. Neurochem Pathol 1986; 5: 309-329.
20. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
21. Ramirez MR, Muraro F, Zylbersztejn DS, Abel CR, Arteni NS, Lavinsky D, et al. Neonatal hypoxia-ischemia reduces ganglioside, phospholipid and cholesterol contents in the rat hippocampus. Neurosci Res 2003; 46: 339-347.
22. Phillis JW, O'Regan MH. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex. Neuroreport 1995; 6: 2010-2012.
23. Liu JR, Ding MP, Wei EQ, Huang JZ, Song Y, Ding Q, et al. Monosialoganglioside protected ischemic rat hippocampal slices through stabilizing expression of N-methyl-D-aspartate receptor subunit. Acta Pharmacol Sin 2004; 25: 727-732.
24. Mahadik SP, Makar TK, Murthy JN, Ortiz A, Wakade CG, Karpiak SE. Temporal changes in superoxide dismutase, glutathione peroxidase, and catalase levels in primary and peri-ischemic tissue. Monosialoganglioside (GM1) treatment effects. Mol Chem Neuropathol 1993; 18: 1-14.
25. Fighera MR, Bonini JS, Frussa-Filho R, Dutra-Filho CS, Hagen ME, Rubin MA, et al. Monosialoganglioside increases catalase activity in cerebral cortex of rats. Free Radic Res 2004; 38: 495-500.
26. Furian AF, Oliveira MS, Royes LF, Fiorenza NG, Fighera MR, Myskiw JC, et al. GM1 ganglioside induces vasodilation and increases catalase content in the brain. Free Radic Biol Med 2007; 43: 924-932.
27. Furian AF, Oliveira MS, Magni DV, Souza MA, Bortoluzzi VT, Bueno LM, et al. L-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain. Neurochem Int 2008; 53: 362-369.
28. Furian AF, Rattmann YD, Oliveira MS, Royes LF, Marques MC, Santos AR, et al. Nitric oxide and potassium channels mediate GM1 ganglioside-induced vasorelaxation. Naunyn Schmiedebergs Arch Pharmacol 2009; 380: 487-495.